Podoplanin expression was positive in 66.2% (92/139) of samples from patients with ESCC (Fig. 2); weak expression was observed in 32.4% (45/139) and strong expression in 33.8% (47/139; Fig. 1). Here, PDPN is linked to esophageal squamous cell carcinoma.